Your search returned 692 results.

Results
	181.	Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts. [electronic resource] by Grant, S Jarvis, W D Turner, A J Wallace, H J Pettit, G R Producer: 19930219 In: British journal of haematology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	182.	In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1. [electronic resource] by Gebbia, V Gebbia, N Rausa, L Sharkis, S J May, W S Producer: 19910320 In: Pharmacological research vol. 22 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	183.	A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study. [electronic resource] by Weitman, S Langevin, A M Berkow, R L Thomas, P J Hurwitz, C A Kraft, A S Dubowy, R L Smith, D L Bernstein, M Producer: 19991122 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 5 Availability: No items available. Save to lists Add to cart (remove)
	184.	The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues. [electronic resource] by Wender, P A Hinkle, K W Koehler, M F Lippa, B Producer: 19991020 In: Medicinal research reviews vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	185.	New drugs in non-Hodgkin's lymphoma. [electronic resource] by Arbuck, S G Sorensen, J M Christian, M C Ho, P Pluda, J M Cheson, B D Producer: 19970731 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 8 Suppl 1 Availability: No items available. Save to lists Add to cart (remove)
	186.	Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patients. [electronic resource] by Stewart, J P McGown, A T Prendiville, J Pettit, G R Fox, B W Arrand, J R Producer: 19940201 In: Cancer chemotherapy and pharmacology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	187.	Pharmacological Interventions for Vascular Targeting in Retinopathy of Prematurity: An Experimental Study. [electronic resource] by Aron, Neelima Nath, Madhu Vardhan Azad, Shorya Chandra, Parijat Vardhan Azad, Raj Velpandian, Thirumurthy Producer: 20180724 In: Indian journal of physiology and pharmacology vol. 60 Availability: No items available. Save to lists Add to cart (remove)
	188.	Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes. [electronic resource] by Wender, P A Lippa, B Park, C M Irie, K Nakahara, A Ohigashi, H Producer: 19990909 In: Bioorganic & medicinal chemistry letters vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	189.	Neuroprotective versus tumorigenic protein kinase C activators. [electronic resource] by Nelson, T J Alkon, D L Producer: 20090521 In: Trends in biochemical sciences vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	190.	A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activity. [electronic resource] by Nakagawa, Yu Yanagita, Ryo C Hamada, Naoko Murakami, Akira Takahashi, Hideyuki Saito, Naoaki Nagai, Hiroshi Irie, Kazuhiro Producer: 20090722 In: Journal of the American Chemical Society vol. 131 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	191.	A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study. [electronic resource] by Tozer, R G Burdette-Radoux, S Berlanger, K Davis, M L Lohmann, R C Rusthoven, J R Wainman, N Zee, B Seymour, L Producer: 20030421 In: Investigational new drugs vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	192.	Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts. [electronic resource] by Dagur, Raghubendra Singh Hambarde, Shashank Chandna, Sudhir Producer: 20150929 In: Molecular and cellular biochemistry vol. 401 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	193.	Bryostatin 1 causes attenuation of TPA‑mediated tumor promotion in mouse skin. [electronic resource] by Zeng, Ning Xu, Yi Wu, Yiping Hongbo, Tang Wu, Min Producer: 20180716 In: Molecular medicine reports vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	194.	Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells. [electronic resource] by Dale, I L Gescher, A Producer: 19890223 In: International journal of cancer vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	195.	A phase II study of bryostatin 1 in metastatic malignant melanoma. [electronic resource] by Propper, D J Macaulay, V O'Byrne, K J Braybrooke, J P Wilner, S M Ganesan, T S Talbot, D C Harris, A L Producer: 19981209 In: British journal of cancer vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	196.	Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model. [electronic resource] by Mohammad, R M Adsay, N V Philip, P A Pettit, G R Vaitkevicius, V K Sarkar, F H Producer: 20011218 In: Anti-cancer drugs vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	197.	Impact of environmental conditions on the marine natural product bryostatin 1. [electronic resource] by Manning, Thomas J Rhodes, Emily Land, Michael Parkman, Render Sumner, Brandy Lam, Tukiet T Marshall, Alan G Phillips, Dennis Producer: 20060829 In: Natural product research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	198.	In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin. [electronic resource] by Kalechman, Y Albeck, M Sredni, B Producer: 19920811 In: Cellular immunology vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	199.	The effects of interleukin-3, bryostatin and thymocytes on erythropoiesis. [electronic resource] by Sharkis, S J Leonard, J P Ihle, J N May, W S Producer: 19890714 In: Annals of the New York Academy of Sciences vol. 554 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	200.	Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes. [electronic resource] by Kazanietz, M G Lewin, N E Gao, F Pettit, G R Blumberg, P M Producer: 19941005 In: Molecular pharmacology vol. 46 Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 692 results.